세계의 첨단 상처 치료 및 봉합 시장 예측(-2030년) : 제품 유형, 상처 유형, 최종사용자, 지역별 분석

According to Stratistics MRC, the Global Advanced Wound Care and Closure Market is accounted for $22.2 billion in 2024 and is expected to reach $33.2 billion by 2030, growing at a CAGR of 6.2% during the forecast period. Advanced wound care and closure are specialized medical interventions and products used to manage and speed up the healing of complex wounds, such as acute wounds from trauma or surgery, as well as chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Advanced dressings, skin substitutes, negative pressure wound therapy (NPWT), and closure products such as tissue adhesives, staples, and sutures are all included. These remedies seek to improve patient outcomes, promote healing, and stop infection.

According to the U.S. government estimates, by the year 2060, the elderly population will be over 77 million. Overall, in the United States approximately 2% of the total population are estimated to be affected by chronic wounds.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular disorders, is a significant driver for the advanced wound care and closure market. These conditions often lead to chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, which require advanced wound care solutions. The growing aging population, which is more susceptible to these diseases, further amplifies this trend. As the number of patients with chronic wounds rises, the demand for advanced wound care products and technologies increases, driving market growth.

Restraint:

High cost of advanced wound care products

The high cost of advanced wound care products poses a significant restraint to market growth. These products often incorporate sophisticated technologies and materials, resulting in higher production costs and, consequently, higher prices for end-users. The expense can be prohibitive for many patients, especially in developing countries or areas with limited healthcare coverage. The cost factor can lead to slower adoption rates and limited market penetration in certain regions.

Opportunity:

Advancements in regenerative medicine

Advancements in regenerative medicine focus on repairing, replacing, or regenerating damaged tissues and organs, offering promising solutions for complex wound healing. Innovations in stem cell therapy, tissue engineering, and growth factors are opening new avenues for treating chronic and acute wounds. These technologies have the potential to accelerate healing, reduce scarring, and improve overall patient outcomes. As research progresses and clinical applications expand, regenerative medicine approaches are likely to become more integrated into advanced wound care protocols.

Threat:

Product recalls and safety concerns

Incidents of product defects, adverse reactions, or unforeseen complications can lead to recalls, damaging both company reputations and consumer trust. Such events may result in regulatory scrutiny, legal liabilities, and financial losses for manufacturers. Safety concerns can also slow down the adoption of new technologies as healthcare providers become more cautious. Additionally, negative publicity surrounding these issues can impact the entire industry, potentially slowing market growth.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the advanced wound care and closure market, causing supply chain issues and postponement of non-emergency procedures. However, it also highlighted the importance of advanced wound care in preventing complications in COVID-19 patients. The pandemic accelerated the adoption of telehealth solutions for wound care management and emphasized the need for infection control measures in wound treatment protocols. These changes are likely to have lasting effects on market trends and product development.

The dressings segment is expected to be the largest during the forecast period

Over the forecasted timeframe, the dressings segment is anticipated to dominate the market share. This dominance can be attributed to the wide range of dressing types available, including foam dressings, hydrocolloid dressings, alginate dressings, and antimicrobial dressings, each catering to specific wound types and healing stages. The versatility and effectiveness of advanced dressings in managing various wound conditions, from chronic ulcers to surgical wounds, contribute to their widespread use. Additionally, ongoing innovations in dressing materials and designs, such as smart dressings with sensors for wound monitoring, are further driving the segment's growth.

The negative pressure wound therapy (NPWT) segment is expected to have the highest CAGR during the forecast period

During the projection period, the negative pressure wound therapy (NPWT) segment is expected to grow at the highest CAGR. This rapid growth can be attributed to the increasing recognition of NPWT's effectiveness in managing complex and hard-to-heal wounds. NPWT systems promote faster healing by creating a controlled negative pressure environment that removes excess fluid, reduces edema, and stimulates granulation tissue formation. The technology's versatility in treating various wound types, including surgical wounds, pressure ulcers, and diabetic foot ulcers, contributes to its growing adoption.

Region with largest share:

During the estimation period, the North America region is expected to capture the largest market share. This dominance can be attributed to several factors, including the region's well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. The prevalence of chronic diseases such as diabetes and obesity, which often lead to complex wounds, is also higher in North America. The region benefits from a strong presence of key market players, driving innovation and product availability. Additionally, favorable reimbursement policies for advanced wound care products and a growing aging population contribute to the market's size.

Region with highest CAGR:

The Asia Pacific region is projected to achieve the highest CAGR during the forecast period. This rapid growth can be attributed to several factors, including the region's large and growing population, increasing healthcare expenditure, and improving healthcare infrastructure. The rising prevalence of chronic diseases, coupled with a growing awareness of advanced wound care techniques, is driving market expansion. Governments in countries like China and India are investing heavily in healthcare modernization, creating opportunities for advanced wound care adoption. The region's expanding medical tourism industry also contributes to market growth.

Key players in the market

Some of the key players in Advanced Wound Care and Closure Market include 3M Company, Smith & Nephew plc, ConvaTec Group plc, Coloplast A/S, Molnlycke Health Care AB, B. Braun Melsungen AG, Johnson & Johnson, Medtronic plc, Cardinal Health, Inc., Paul Hartmann AG, Integra LifeSciences Holdings Corporation, Baxter International Inc., Essity AB, Acelity L.P. Inc., Organogenesis Holdings Inc., Hollister Incorporated, MiMedx Group, Inc., and Ethicon, Inc.

Key Developments:

In October 2024, Molnlycke Health Care AB acquired P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn wound cleansing and moisturizing solutions, to expand its wound care portfolio.

In April 2024, Smith+Nephew, the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact, allowing it to be easily carried or worn. It features a discreet canister and operates quietly so as not to draw attention or disturb the patients' daily activities.

In January 2024, 3M Company received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity to develop new solutions for infection prevention, wound management, and wound healing, focusing on treatment strategies for emergency settings and mass casualty situations.

Product Types Covered:

• Dressings
• Negative Pressure Wound Therapy (NPWT)
• Skin Substitutes
• Wound Cleansers and Disinfectants
• Sutures and Staples
• Adhesives and Sealants
• Wound Care Devices

Wound Types Covered:

• Chronic Wounds
• Acute Wounds

End Users Covered:

• Hospitals
• Home Healthcare
• Ambulatory Surgical Centers (ASCs)
• Wound Care Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Advanced Wound Care and Closure Market, By Product Type

• 5.1 Introduction
• 5.2 Dressings
  • 5.2.1 Alginate
  • 5.2.2 Hydrocolloid
  • 5.2.3 Hydrogel
  • 5.2.4 Foam
  • 5.2.5 Other Dressings
• 5.3 Negative Pressure Wound Therapy (NPWT)
• 5.4 Skin Substitutes
• 5.5 Wound Cleansers and Disinfectants
• 5.6 Sutures and Staples
  • 5.6.1 Absorbable Sutures
  • 5.6.2 Non-Absorbable Sutures
  • 5.6.3 Surgical Staples
• 5.7 Adhesives and Sealants
  • 5.7.1 Tissue Adhesives
  • 5.7.2 Surgical Sealants
• 5.8 Wound Care Devices
  • 5.8.1 Debridement Tools
  • 5.8.2 Wound Irrigation Systems
  • 5.8.3 Other Wound Care Devices

6 Global Advanced Wound Care and Closure Market, By Wound Type

• 6.1 Introduction
• 6.2 Chronic Wounds
  • 6.2.1 Diabetic Foot Ulcers
  • 6.2.2 Pressure Ulcers
  • 6.2.3 Venous Leg Ulcers
  • 6.2.4 Other Chronic Wounds
• 6.3 Acute Wounds
  • 6.3.1 Surgical Wounds
  • 6.3.2 Traumatic Wounds
  • 6.3.3 Burns
  • 6.3.4 Other Acute Wounds

7 Global Advanced Wound Care and Closure Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Home Healthcare
• 7.4 Ambulatory Surgical Centers (ASCs)
• 7.5 Wound Care Centers
• 7.6 Other End Users

8 Global Advanced Wound Care and Closure Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 3M Company
• 10.2 Smith & Nephew plc
• 10.3 ConvaTec Group plc
• 10.4 Coloplast A/S
• 10.5 Molnlycke Health Care AB
• 10.6 B. Braun Melsungen AG
• 10.7 Johnson & Johnson
• 10.8 Medtronic plc
• 10.9 Cardinal Health, Inc.
• 10.10 Paul Hartmann AG
• 10.11 Integra LifeSciences Holdings Corporation
• 10.12 Baxter International Inc.
• 10.13 Essity AB
• 10.14 Acelity L.P. Inc.
• 10.15 Organogenesis Holdings Inc.
• 10.16 Hollister Incorporated
• 10.17 MiMedx Group, Inc.
• 10.18 Ethicon, Inc.